Palogic Value Management’s Texas Instruments TXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Sell
5,098
-52
-1% -$14.4K 0.5% 41
2026
Q1
$1,000K Buy
5,150
+193
+4% +$39.1K 0.42% 75
2025
Q4
$860K Buy
4,957
+178
+4% +$30.5K 0.36% 86
2025
Q3
$878K Buy
4,779
+55
+1% +$10.8K 0.35% 82
2025
Q2
$981K Buy
4,724
+274
+6% +$48.6K 0.4% 76
2025
Q1
$800K Buy
4,450
+643
+17% +$120K 0.35% 87
2024
Q4
$714K Buy
3,807
+22
+0.6% +$4.4K 0.27% 98
2024
Q3
$782K Buy
3,785
+83
+2% +$16.7K 0.27% 95
2024
Q2
$720K Buy
3,702
+187
+5% +$34.5K 0.31% 89
2024
Q1
$612K Buy
3,515
+287
+9% +$47.9K 0.26% 97
2023
Q4
$550K Buy
3,228
+482
+18% +$74.7K 0.24% 100
2023
Q3
$437K Buy
2,746
+89
+3% +$15.2K 0.21% 106
2023
Q2
$478K Buy
2,657
+230
+9% +$39.6K 0.22% 103
2023
Q1
$451K Buy
2,427
+453
+23% +$79.6K 0.22% 104
2022
Q4
$326K Buy
+1,974
New +$329K 0.17% 117

Other funds holding TXN

Palogic Value Management's TXN Position: Q2 2026 in Review

Palogic Value Management reduced its Texas Instruments (TXN) stake by 1% in Q2 2026, selling an estimated $14.4K and leaving 5,098 shares worth $1.52M. The position accounts for 0.5% of the portfolio, ranked #41.

Palogic Value Management first reported a position in TXN in Q4 2022 and has held it in 15 quarters since. 2,846 funds tracked by Wall St. Rank hold TXN as of Q2 2026.

  • Palogic Value Management held 5,098 shares of Texas Instruments worth $1.52M as of Q2 2026.
  • Palogic Value Management sold 52 Texas Instruments shares in Q2 2026, an estimated $14.4K.
  • Texas Instruments made up 0.5% of Palogic Value Management's portfolio in Q2 2026, its #41 holding.
  • Palogic Value Management first reported a position in Texas Instruments in Q4 2022 and has held it in 15 quarters since.
  • 2,846 funds tracked by Wall St. Rank held Texas Instruments as of Q2 2026.

Based on Palogic Value Management's 13F filing for Q2 2026, filed 14 Aug 2026.